Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Maravai LifeSciences Holdings Inc shares valued at $509,331 were purchased by Brust Bernd on Nov 11 ’25. At $3.24 per share, Brust Bernd acquired 157,201 shares. The insider’s holdings grew to 157,201 shares worth approximately $0.51 million following the completion of this transaction.
Also, Brust Bernd purchased 93,358 shares, netting a total of over 299,679 in proceeds. Following the buying of shares at $3.21 each, the insider now holds 250,559 shares.
Before that, ORESHACK KURT had sold 25,000 shares from its account. In a trade valued at $125,750, the General Counsel traded Maravai LifeSciences Holdings Inc shares for $5.03 each. Upon closing the transaction, the insider’s holdings decreased to 25,000 shares, worth approximately $0.54 million.
As published in a research note from Robert W. Baird on February 26, 2025, Maravai LifeSciences Holdings Inc [MRVI] has been rated down from an Outperform to a Neutral and the price target has been revised to $3 from $9. Analysts at Guggenheim started covering the stock with ‘”a Neutral”‘ outlook in a report released in mid December. As of December 05, 2024, Goldman has decreased its “Neutral” rating to a “Sell” for MRVI. Earlier on November 14, 2024, Wolfe Research initiated its rating. Their recommendation was “a Peer perform” for MRVI stock.
Analyzing MRVI Stock Performance
The stock’s lowest price that day was $3.22, but it reached a high of $3.29 in the same session. During the last five days, there has been a surge of approximately 12.46%. Over the course of the year, Maravai LifeSciences Holdings Inc shares have dropped approximately -43.77%. Shares of the company reached a 52-week high of $6.21 on 01/08/25 and a 52-week low of $1.66 on 04/17/25.
Support And Resistance Levels for Maravai LifeSciences Holdings Inc (MRVI)
According to the 24-hour chart, there is a support level at 3.22, which, if violated, would cause prices to drop to 3.18. In the upper region, resistance lies at 3.29. The next price resistance is at 3.32. RSI (Relative Strength Index) is 56.15 on the 14-day chart, showing neutral technical sentiment.
Is Maravai LifeSciences Holdings Inc subject to short interest?
Stocks of Maravai LifeSciences Holdings Inc saw a sharp steep in short interest on 2025-10-31 dropping by -0.11 million shares to 12.99 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 13.1 million shares. A decline of -0.84% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.81 of the overall float, the days-to-cover ratio (short ratio) decline to 7.81.
Which companies own the most shares of Maravai LifeSciences Holdings Inc (MRVI)?
In terms of Maravai LifeSciences Holdings Inc share price expectations, FactSet research, analysts set an average price target of 16 in the next 12 months, up nearly 392.31% from the previous closing price of $3.25. Analysts anticipate Maravai LifeSciences Holdings Inc stock to reach 25 by 2025, with the lowest price target being 5. In spite of this, 7 analysts ranked Maravai LifeSciences Holdings Inc stock as Buy at the end of 2025.
